M-CAM expression as marker of poor prognosis in epithelial ovarian cancer.
about
CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell linesLesser-Known Molecules in Ovarian CarcinogenesisLabel-free detection and molecular profiling of exosomes with a nano-plasmonic sensorIntegrated Magneto-Electrochemical Sensor for Exosome Analysis.Evaluation of CD146 as Target for Radioimmunotherapy against OsteosarcomaMolecular cues on obesity signals, tumor markers and endometrial cancer.Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis.Extending the chinchilla middle ear epithelial model for mucin gene investigation.Ovarian cancer biomarkers for molecular biosensors and translational medicine.CD146 expression in human breast cancer cell lines induces phenotypic and functional changes observed in Epithelial to Mesenchymal TransitionMolecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cellsCD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer.Prognostic value of melanoma cell adhesion molecule expression in cancers: a meta-analysisDual Roles of METCAM in the Progression of Different Cancers.METCAM/MUC18 is a novel tumor and metastasis suppressor for the human ovarian cancer SKOV3 cellsCD146 as an adverse prognostic factor in uterine sarcoma.CD146 expression correlates with epithelial-mesenchymal transition markers and a poor prognosis in gastric cancerDecreased expression of mucin 18 is associated with unfavorable postoperative prognosis in patients with clear cell renal cell carcinomaMCAM is a novel metastasis marker and regulates spreading, apoptosis and invasion of ovarian cancer cellsCD146 is a potential marker for the diagnosis of malignancy in cervical and endometrial cancerEvaluating cell lines as tumour models by comparison of genomic profiles.ImmunoPET Imaging of CD146 Expression in Malignant Brain TumorsCD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody.Lovastatin Reduces Stemness via Epigenetic Reprograming of BMP2 and GATA2 in Human Endometrium and Endometriosis.Melanoma biomolecules: independently identified but functionally intertwined.The involvement of CD146 and its novel ligand Galectin-1 in apoptotic regulation of endothelial cells.The multifaceted role of CD146/MCAM in the promotion of melanoma progression.Recognition of CD146 as an ERM-binding protein offers novel mechanisms for melanoma cell migration.IGFBP-4 activates the Wnt/beta-catenin signaling pathway and induces M-CAM expression in human renal cell carcinoma.Clinicopathological impact of ABCC1/MRP1 and ABCC4/MRP4 in epithelial ovarian carcinoma.Correlation of CD146 expression and clinicopathological characteristics in esophageal squamous cell carcinoma.MCAM expression is associated with poor prognosis in non-small cell lung cancer.Identification of CD146 expression, angiogenesis, and lymphangiogenesis as progression, metastasis, and poor-prognosis related markers for gallbladder adenocarcinoma.CD146 mediates VEGF-induced melanoma cell extravasation through FAK activation.The Prevalence of CD146 Expression in Breast Cancer Subtypes and Its Relation to Outcome.Specific mesothelial signature marks the heterogeneity of mesenchymal stem cells from high-grade serous ovarian cancer.
P2860
Q24654220-46AA5BA9-F045-4293-866A-ABE6C13B2697Q26784533-1E473D47-A6DB-4539-871F-ADCE4F633D15Q28238644-C7DAC825-D907-41F6-8E16-4F40FB50FB36Q28272483-9D983128-F93F-4438-B6D2-55E0ECAEA703Q28552916-A6B42990-028A-405B-ABCD-1F7F5881288FQ30372789-C5B44376-4B42-442B-BC3C-81D8AA216E66Q33835183-8362CFD1-1921-4C12-9E5A-159BE2D58B76Q34069192-ED7D4D80-658F-4A9B-AC9B-C61E6770D178Q34150097-0A6B6823-8857-4197-BF4A-CF7E14341CECQ34405536-17D45D17-827C-4941-8BC1-B95B0445A8B0Q35640277-22F8F478-BBBA-469F-A67F-0A1BC297D75EQ35709153-243F036C-155A-4DC9-AC71-59F38AF50080Q35835752-DFC7AC8D-EBF3-4CBB-B291-B2A10C2CE3FEQ35875771-BCB14ED9-7A1A-4562-A13A-D5CCDB239E1FQ35932501-79E05599-A70B-4733-AEBB-23A193FB66FDQ35986639-83323F34-CCB0-4507-AF3C-766CFEBEE65FQ36057178-97339C36-4038-4203-AC67-074A2CB75967Q36261594-C0B9D842-3FD0-478D-ADCC-F775E2D4C64AQ36285331-A459BC8E-2216-4447-B4E3-96E9FC459FB2Q36774284-76E33C86-C6AB-420D-9124-EA23E995F232Q37025950-C2D006B8-4681-4403-A86C-B0FC203F1DC5Q37072090-184CA2C5-C4EE-4948-98EC-E15CF76CF6DAQ37202324-91BE7226-1142-4BC3-9CDA-5C4CCFB4E499Q37590926-A0CBF663-AEC3-44B0-BCC6-1FECEEC7B26CQ38143977-D0EA2AC3-0662-4126-AC59-D167977AEA64Q38319415-AD6AD29A-C247-4708-BD49-1A97EE67FA0FQ39038566-4C58A8A9-2B5B-4A4E-A34C-24AB3BFC974DQ39513736-C1EE3808-B8B6-40AD-B91A-DFD3EA0926B1Q39612044-17DF0326-099E-4554-993C-9E1194A4D440Q41811277-DB3FA1C2-33A6-48C3-BF9F-C47823937BC5Q42006550-30F91E97-E127-45CF-ACC6-CF6A6595E716Q43450949-91B3DC56-C4A2-4B08-80C0-68E0937E5C34Q50176110-8CE375D2-EDAA-453B-8B92-C01FDA4CFB26Q51030489-848FB39C-E0BC-4FC0-9F19-38A56DE6FEFFQ53686719-A5A06100-4010-4A70-BF8F-0ECB858840E5Q54737381-5ADF1BAA-F0E4-4347-AC84-F865D1C54933
P2860
M-CAM expression as marker of poor prognosis in epithelial ovarian cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
M-CAM expression as marker of poor prognosis in epithelial ovarian cancer.
@en
type
label
M-CAM expression as marker of poor prognosis in epithelial ovarian cancer.
@en
prefLabel
M-CAM expression as marker of poor prognosis in epithelial ovarian cancer.
@en
P2093
P2860
P50
P356
P1476
M-CAM expression as marker of poor prognosis in epithelial ovarian cancer.
@en
P2093
Bruna Zeni
Claudia Griso
Cristina Pegoraro
Daniela Aldovini
Dolores Di Vizio
Emanuela Balladore
Enzo Galligioni
Marina Zannoni
Mattia Barbareschi
Silvana Canevari
P2860
P304
P356
10.1002/IJC.22082
P577
2006-10-01T00:00:00Z